Mortality in Barrett's oesophagus: results from a population based study - PubMed (original) (raw)
Mortality in Barrett's oesophagus: results from a population based study
L A Anderson et al. Gut. 2003 Aug.
Abstract
Background: Patients with Barrett's oesophagus have an increased risk of oesophageal adenocarcinoma but this cancer only accounts for a small proportion of deaths in these patients. Other causes of death are reportedly raised in this group. We examined cause specific mortality among individuals in a population based Barrett's oesophagus register.
Methods: We constructed a register of all patients diagnosed with columnar mucosa (including specialised intestinal metaplasia) of the oesophagus within Northern Ireland between 1993 and 1999. Deaths occurring within this cohort until 31 December 2000 were identified and mortality rates were compared with the general population.
Results: Overall mortality was not raised in Barrett's patients. During 7413 person years of follow up in 2373 patients there were 253 deaths (standardised mortality ratio (SMR) 96 (95% confidence interval (CI) 84-107)). Mortality from oesophageal cancer was raised in patients with specialised intestinal metaplasia (SMR 774 (95% CI 317-1231)) but only 4.7% of patients died from this cancer. Mortality from stroke (SMR 65 (95% CI 37-93)) was significantly lower than the general population while mortality from non-cancerous digestive system diseases was significantly higher (SMR 211 (95% CI 111-311)). Mortality rates from all other causes were similar to those of the general population.
Conclusions: This study demonstrates that the overall mortality rate in patients with Barrett's oesophagus is closely similar to that of the general population. Oesophageal cancer mortality was raised but is an uncommon cause of death in these patients who also appear to have a reduced risk of death from stroke.
Comment in
- Barrett's oesophagus: epidemiology comes up with a surprise.
Heading RC. Heading RC. Gut. 2003 Aug;52(8):1079-80. doi: 10.1136/gut.52.8.1079. Gut. 2003. PMID: 12865261 Free PMC article. No abstract available.
Similar articles
- Mortality rates in patients with Barrett's oesophagus.
Moayyedi P, Burch N, Akhtar-Danesh N, Enaganti SK, Harrison R, Talley NJ, Jankowski J. Moayyedi P, et al. Aliment Pharmacol Ther. 2008 Feb 15;27(4):316-20. doi: 10.1111/j.1365-2036.2007.03582.x. Epub 2007 Dec 6. Aliment Pharmacol Ther. 2008. PMID: 18062791 - Incidence of colorectal cancer in a population-based cohort of patients with Barrett's oesophagus.
Murphy SJ, Anderson LA, Mainie I, Fitzpatrick DA, Johnston BT, Watson RG, Gavin AT, Murray LJ. Murphy SJ, et al. Scand J Gastroenterol. 2005 Dec;40(12):1449-53. doi: 10.1080/00365520510023828. Scand J Gastroenterol. 2005. PMID: 16316894 - Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study.
Solaymani-Dodaran M, Logan RF, West J, Card T. Solaymani-Dodaran M, et al. Am J Gastroenterol. 2005 Dec;100(12):2616-21. doi: 10.1111/j.1572-0241.2005.00340.x. Am J Gastroenterol. 2005. PMID: 16393209 - Barrett's oesophagus: the new endoscopic modalities have a future.
Deviere J. Deviere J. Gut. 2005 Mar;54 Suppl 1(Suppl 1):i33-7. doi: 10.1136/gut.2004.041574. Gut. 2005. PMID: 15711006 Free PMC article. Review. - Should patients with Barrett's oesophagus be kept under surveillance? The case for.
Armstrong D. Armstrong D. Best Pract Res Clin Gastroenterol. 2008;22(4):721-39. doi: 10.1016/j.bpg.2008.03.002. Best Pract Res Clin Gastroenterol. 2008. PMID: 18656826 Review.
Cited by
- Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus.
Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Krishnadath KK, Nichols FC 3rd, Lutzke LS, Borkenhagen LS. Prasad GA, et al. Gastroenterology. 2007 Apr;132(4):1226-33. doi: 10.1053/j.gastro.2007.02.017. Epub 2007 Feb 7. Gastroenterology. 2007. PMID: 17408660 Free PMC article. - American Gastroenterological Association technical review on the management of Barrett's esophagus.
Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ; American Gastroenterological Association. Spechler SJ, et al. Gastroenterology. 2011 Mar;140(3):e18-52; quiz e13. doi: 10.1053/j.gastro.2011.01.031. Gastroenterology. 2011. PMID: 21376939 Free PMC article. Review. No abstract available. - Barrett's oesophagus: epidemiology, cancer risk and implications for management.
de Jonge PJ, van Blankenstein M, Grady WM, Kuipers EJ. de Jonge PJ, et al. Gut. 2014 Jan;63(1):191-202. doi: 10.1136/gutjnl-2013-305490. Epub 2013 Oct 3. Gut. 2014. PMID: 24092861 Free PMC article. Review. - Evidence-based endoscopic management of Barrett's esophagus.
Yachimski P, Hur C. Yachimski P, et al. Gastroenterol Rep (Oxf). 2015 Feb;3(1):54-62. doi: 10.1093/gastro/gou059. Epub 2014 Sep 17. Gastroenterol Rep (Oxf). 2015. PMID: 25237038 Free PMC article. Review. - Barrett's esophagus and the increasing role of endoluminal therapy.
Smith MS, Lightdale CJ. Smith MS, et al. Therap Adv Gastroenterol. 2008 Sep;1(2):121-42. doi: 10.1177/1756283X08095883. Therap Adv Gastroenterol. 2008. PMID: 21180521 Free PMC article.
References
- Hansson LE, Sparen P, Nyren O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer 1993;54:402–7. - PubMed
- Botterweck AAM, Schouten LJ, Volovics A, et al. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000;29:645–54. - PubMed
- Powell J, McConkey CC. The rising trend in oesophageal adenocarcinoma and gastric cardia. Eur J Cancer Prev 1992;1:265–9. - PubMed
- Moller H. Incidence of cancer of oesophagus, cardia and stomach in Denmark. Eur J Cancer Prev 1992;1:159–64. - PubMed
- Blot WJ, McLaughlin JK. The changing epidemiology of esophageal cancer. Semin Oncol 1999;26(suppl 15):2–8. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical